Home › Funds › New Vernon Capital Holdings II LLC › PTCT

New Vernon Capital Holdings II LLC position in PTCT

PTC THERAPEUTICS INC · Health Care

New Vernon Capital Holdings II LLC reported holding 3,668 shares of PTCT (PTC THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$299K, representing 0.16% of its reported portfolio and ranking #32 among its reported holdings. New Vernon Capital Holdings II LLC has disclosed PTCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)3.67K sh
Reported value held$299.20K
Portfolio Weight0.16%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How New Vernon Capital Holdings II LLC's PTCT position evolved

New Vernon Capital Holdings II LLC first disclosed a stake in PTCT in Q3 2025 at 3,675 shares (US$226K). The position peaked in Q2 2026 at 3,668 shares, worth US$299K. Across 4 filings, New Vernon Capital Holdings II LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,668 shares valued at US$299K.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 3.67K $225.53K New
Q4 2025 3.67K $278.62K Hold
Q1 2026 3.67K $249.90K Hold
Q2 2026 3.67K $299.20K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PTCT and 13F data

PTCT (PTC THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in PTCT — the largest reported positions include RTW INVESTMENTS, LP (US$631.9M), TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$159.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTCT

All PTCT fund holders →

FAQ

How long has New Vernon Capital Holdings II LLC held PTCT?

New Vernon Capital Holdings II LLC has disclosed PTCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is New Vernon Capital Holdings II LLC's current position in PTCT?

As of Q2 2026, New Vernon Capital Holdings II LLC holds 3.67K shares of PTCT (PTC THERAPEUTICS INC), valued at $299.20K, representing 0.16% of its reported portfolio and ranking #32.

Has New Vernon Capital Holdings II LLC been buying or selling PTCT?

In the latest 13F filing (Q2 2026), New Vernon Capital Holdings II LLC held unchanged its position in PTCT. The position peaked in Q2 2026 at 3.67K shares.

Which other funds hold PTCT?

Other major institutional holders of PTCT include RTW INVESTMENTS, LP, TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.